Stay updated with breaking news from Nuclear Export. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Fox Run Management L.L.C. purchased a new position in shares of Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Rating) during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm purchased 28,823 shares of the company’s stock, valued at approximately $98,000. A number of other hedge funds have […]
Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Rating) was the target of a significant decline in short interest during the month of April. As of April 15th, there was short interest totalling 17,760,000 shares, a decline of 7.0% from the March 31st total of 19,090,000 shares. Based on an average trading volume of 2,350,000 shares, the […]
Karyopharm Therapeutics Inc. (NASDAQ:KPTI – Get Rating) was the target of a significant decline in short interest during the month of April. As of April 15th, there was short interest totalling 17,760,000 shares, a decline of 7.0% from the March 31st total of 19,090,000 shares. Based on an average daily trading volume, of 2,350,000 shares, […]
– Relapsed/Refractory MDS Patients Achieved Median Overall Survival of 8.7 months – – Historically, Median Overall Survival in this Hard to Treat Patient Population is Only... | May 3, 2023
NEWTON, Mass., May 1, 2023 /PRNewswire/ -- Karyopharm Therapeutics Inc. , a commercial-stage pharmaceutical company pioneering novel cancer therapies, today announced that the Company granted an... | May 1, 2023